Features March 2011 Issue

Drug-Eluting and Bare-Metal Stents Both Safe in Large Arteries

Patients with drug-eluting stents also have lower rates of revascularization.

When a large coronary artery becomes narrowed due to plaque build-up, a drug-eluting stent (DES) is just as safe as a bare-metal stent (BMS) for opening a narrowed vessel, according to a large study presented at the 2010 American Heart Associationís Scientific Sessions. Patients with DES and BMS had similar rates of deaths and heart attacks. The study compared the safety and effectiveness of three types of stent: bare-metal stents, stents that eluted the drug sirolimus and those that eluted the drug everolimus.

To continue reading this article you must be a paid subscriber.

Subscribe to Heart Advisor

Get the next year of HEART ADVISOR for just $20. That's a savings of $19 off the regular rate.

With your paid subscription you will receive unlimited access to all of our online content. That is over a decade of previous issues from Cleveland Clinic, the hospital rated #1 in cardiac care by U.S. News & World Report - free of charge.

Subscriber Log In

Forgot your password? Click Here.

Already subscribe but haven't registered for all the benefits of the website? Click here.